Discovery of a peptide proteolysis-targeting chimera (PROTAC) drug of p300 for prostate cancer therapy.
Zhang D, Ma B, Liu D, Wu W, Zhou T, Gao Y, Yang C, Jian Y, Fan Y, Qian Y, Ma J, Gao Y, Chen Y, Xu S, Li L.
Zhang D, et al. Among authors: gao y.
EBioMedicine. 2024 Jul;105:105212. doi: 10.1016/j.ebiom.2024.105212. Epub 2024 Jul 1.
EBioMedicine. 2024.
PMID: 38954976
Free PMC article.